Common Stock, Shares Authorized |
900M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
31.2M |
shares |
+99.5% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.04 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
134K |
USD |
-93.3% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
82.3M |
USD |
+14.8% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
82.3M |
USD |
+14.8% |
Q4 2024 |
FY 2024 |
Operating Lease, Liability |
6K |
USD |
-68.4% |
Q4 2023 |
FY 2024 |
Lessee, Operating Lease, Liability, to be Paid |
6K |
USD |
-77.8% |
Q4 2023 |
FY 2023 |
Property, Plant and Equipment, Gross |
30.9M |
USD |
-40.3% |
Q2 2025 |
Q2 2025 |
Operating Lease, Liability, Current |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
6K |
USD |
-77.8% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
71K |
USD |
-99.8% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
2.5M |
shares |
|
Q1 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.04 |
USD/shares |
|
Q2 2024 |
FY 2024 |